Press Releases 2020

  • Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy

    Liminal BioSciences Joins CoVIg Plasma Alliance to Contribute to Development of Potential New COVID-19 Therapy

    LMNL announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences Inc., has joined the CoVIg-19 Plasma Alliance.

    Read Article
  • ×

    Get the updates before everyone else.

    First Name
    Last Name
    * By completing and submitting this form, you understand and agree that use of Liminal BioSciences' web site is subject to Liminal BioSciences Privacy Policy
    !
    Thank you!
    Error - something went wrong!
  • Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors

    Liminal BioSciences Commences Collection of Convalescent Plasma from COVID-19 Recovered Donors

    LMNL today announced that Prometic Plasma Resources, a subsidiary of Liminal BioSciences, has commenced the collection of convalescent plasma from donors who have recovered from COVID-19.

    Read Article
  • Liminal BioSciences Provides Guidance on Certain Expected Key Milestones For 2020

    Liminal BioSciences Provides Guidance on Certain Expected Key Milestones For 2020

    LMNL today provided a guidance update on the timing of certain expected key milestones for 2020

    Read Article
  • Liminal BioSciences to present at Raymond James Human Health Innovation Conference

    Liminal BioSciences to present at Raymond James Human Health Innovation Conference

    Liminal BioSciences to present at Raymond James Human Health Innovation Conference

    Read Article
  • Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting of Shareholders (AGM)

    Liminal Announces Voting Results of Its 2020 Annual And Special General Meeting of Shareholders (AGM)

    Read Article
  • Liminal BioSciences to present at Jefferies Virtual Healthcare Conference

    Liminal BioSciences to present at Jefferies Virtual Healthcare Conference

    Liminal BioSciences to present at Jefferies Virtual Healthcare Conference 2020

    Read Article
  • Liminal BioSciences Reports Q1 2020 Results

    Liminal BioSciences Reports Q1 2020 Results

    Liminal BioSciences Reports Q1 2020 Results

    Read Article
  • Liminal BioSciences comments on Coronavirus (Covid-19)

    Liminal BioSciences comments on Coronavirus (Covid-19)

    LMNL commented today on the impact of the current COVID-19 pandemic on its operations

    Read Article
  • Liminal BioSciences reports fourth quarter and 2019 year end results

    Liminal BioSciences reports fourth quarter and 2019 year end results

    LMNL today reported its financial results for the fourth quarter and year-ended December 31, 2019.

    Read Article
  • Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast

    Liminal BioSciences to report its fourth quarter and year-end 2019 financial results and hold conference call/webcast

    LMNL announced today it will report its financial results for the fourth quarter and financial year ended December 31, 2019 on Friday March 20, 2020 after market close.

    Read Article
  • Liminal BioSciences announces scientific presentations at upcoming Keystone Symposia

    Liminal BioSciences announces scientific presentations at upcoming Keystone Symposia

    LMNL announced the Company and its collaborators will present scientific findings at two upcoming Keystone Symposia

    Read Article
  • Liminal BioSciences announces upcoming investor presentation at BIO CEO & investor conference

    Liminal BioSciences announces upcoming investor presentation at BIO CEO & investor conference

    Members of the management team will provide a business overview and update at the BIO CEO & Investor Conference taking place February 10-11, 2020 in New York, USA.

    Read Article
  • Liminal BioSciences outlines corporate priorities for 2020

    Liminal BioSciences outlines corporate priorities for 2020

    Read Article
  • loading
    Loading More...